A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)
Clinical trial NCT01321554 · COMPLETED
Trial details
- NCT number
- NCT01321554
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-17
- Primary completion
- 2013-11-15
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.